Moreover, the protective role of high levels of cystatin C in tissue homogenates was suggested, as it had been proposed for some other cysteine proteinase inhibitors by the survival results in breast and lung cancer as well as in SCCHN. The gene discussed is CST3; the disease is head and neck squamous cell carcinoma.